Marco Dal Molin

8.4k total citations · 1 hit paper
33 papers, 2.1k citations indexed

About

Marco Dal Molin is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Marco Dal Molin has authored 33 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 16 papers in Surgery and 16 papers in Cancer Research. Recurrent topics in Marco Dal Molin's work include Pancreatic and Hepatic Oncology Research (28 papers), Cancer Genomics and Diagnostics (13 papers) and Neuroendocrine Tumor Research Advances (8 papers). Marco Dal Molin is often cited by papers focused on Pancreatic and Hepatic Oncology Research (28 papers), Cancer Genomics and Diagnostics (13 papers) and Neuroendocrine Tumor Research Advances (8 papers). Marco Dal Molin collaborates with scholars based in United States, Germany and Italy. Marco Dal Molin's co-authors include Christopher L. Wolfgang, Michael Goggins, Ralph H. Hruban, Anirban Maitra, Hanno Matthaei, Richard D. Schulick, Marcia Irene Canto, Bert Vogelstein, Kenneth W. Kinzler and Amanda L. Blackford and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

Marco Dal Molin

31 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development

2011 562 citations Jian Wu, Hanno Matthaei et al. Science Translational Medicine profile →

Peers

Countries citing papers authored by Marco Dal Molin

Since Specialization

Citations

This map shows the geographic impact of Marco Dal Molin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Dal Molin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Dal Molin more than expected).

Fields of papers citing papers by Marco Dal Molin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Dal Molin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Dal Molin. The network helps show where Marco Dal Molin may publish in the future.

Co-authorship network of co-authors of Marco Dal Molin

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Dal Molin. A scholar is included among the top collaborators of Marco Dal Molin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Dal Molin. Marco Dal Molin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multiregion Genomic Analysis of Human Pancreatic Mucinous Cystic Neoplasms 2025 ·Modern Pathology ·(unknown), Kohei Fujikura, Alicia M. Braxton, Jae W. Lee, (unknown), (unknown), (unknown), Jiayun Lu, Liping Jiang, Xiaobing Wang, (unknown), Marco Dal Molin, Hao Wang, Lodewijk A.A. Brosens, Jin He, Satomi Kawamoto, Yuchen Jiao, Laura D. Wood	2
2	ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1 2024 ·eLife ·Jordina Rincón-Torroella, Marco Dal Molin, Brian J. Mog, (unknown), Evangeline Watson, Nicolas Wyhs, Shun Ishiyama, (unknown), Il Minn, Nilofer S. Azad, Chetan Bettegowda, Nickolas Papadopoulos, Kenneth W. Kinzler, Shibin Zhou, Bert Vogelstein, Kathleen L. Gabrielson, Surojit Sur	0
3	Limited Role for Routine Restaging After Neoadjuvant Therapy in Locally Advanced Rectal Cancer 2020 ·Journal of Surgical Research ·(unknown), Marco Dal Molin, Christopher Laird, Jason K. Molitoris, Andrea C. Bafford	4
4	Predicting the Grade of Dysplasia of Pancreatic Cystic Neoplasms Using Cyst Fluid DNA Methylation Markers 2017 ·Clinical Cancer Research ·Tatsuo Hata, Marco Dal Molin, Seung‐Mo Hong, Koji Tamura, Masaya Suenaga, Jun Yu, (unknown), Matthew J. Weiss, Christopher L. Wolfgang, Anne Marie Lennon, Ralph H. Hruban, Michael Goggins	59
5	Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid 2017 ·Journal of Molecular Diagnostics ·Tatsuo Hata, Marco Dal Molin, (unknown), Tae Jun Song, Christopher L. Wolfgang, James R. Eshleman, Ralph H. Hruban, Michael Goggins	15
6	Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenocarcinoma 2017 ·Annals of Surgical Oncology ·Marco Dal Molin, Amanda L. Blackford, (unknown), Aaron Brant, Christy J. Cho, Neda Rezaee, Jun Yu, Jin He, Matthew J. Weiss, Ralph H. Hruban, Christopher L. Wolfgang, Michael Goggins	8
7	Cyst Fluid Telomerase Activity Predicts the Histologic Grade of Cystic Neoplasms of the Pancreas 2016 ·Clinical Cancer Research ·Tatsuo Hata, Marco Dal Molin, Masaya Suenaga, Jun Yu, Meredith E. Pittman, Matthew J. Weiss, Marcia Irene Canto, Christopher L. Wolfgang, Anne Marie Lennon, Ralph H. Hruban, Michael Goggins	34
8	Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis 2015 ·Clinical Cancer Research ·Marco Dal Molin, Ming Zhang, Roeland F. de Wilde, Niki A. Ottenhof, Neda Rezaee, Christopher L. Wolfgang, Amanda L. Blackford, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos, Ralph H. Hruban, Anirban Maitra, Laura D. Wood	74
9	Targeted next‐generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 2014 ·The Journal of Pathology ·Eliana Amato, Marco Dal Molin, Andrea Mafficini, Jun Yu, Giuseppe Malleo, Borislav C. Rusev, Matteo Fassan, Davide Antonello, Yoshihiko Sadakari, M. Paola Castelli, Giuseppe Zamboni, Anirban Maitra, Roberto Salvia, Ralph H. Hruban, Claudio Bassi, Paola Capelli, Rita T. Lawlor, Michael Goggins, Aldo Scarpa	235
10	GNAS Sequencing Identifies IPMN-specific Mutations in a Subgroup of Diminutive Pancreatic Cysts Referred to as “Incipient IPMNs” 2014 ·The American Journal of Surgical Pathology ·Hanno Matthaei, Jian Wu, Marco Dal Molin, Chanjuan Shi, Sven Perner, Glen Kristiansen, Philipp Lingohr, Jörg C. Kalff, Christopher L. Wolfgang, Kenneth W. Kinzler, Bert Vogelstein, Anirban Maitra, Ralph H. Hruban	37
11	Outcome of superior mesenteric-portal vein resection during pancreatectomy for borderline ductal adenocarcinoma: results of a prospective comparative study 2014 ·Langenbeck s Archives of Surgery ·Federico Selvaggi, Giuseppe Mascetta, Despoina Daskalaki, Marco Dal Molin, Roberto Salvia, Giovanni Butturini, Carlo Cellini, Claudio Bassi	16
12	Clinicopathological Correlates of Activating GNAS Mutations in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 2013 ·Annals of Surgical Oncology ·Marco Dal Molin, Hanno Matthaei, Jian Wu, Amanda L. Blackford, Marija Debeljak, Neda Rezaee, Christopher L. Wolfgang, Giovanni Butturini, Roberto Salvia, Claudio Bassi, Michael Goggins, Kenneth W. Kinzler, Bert Vogelstein, James R. Eshleman, Ralph H. Hruban, Anirban Maitra	122
13	miRNA Biomarkers in Cyst Fluid Augment the Diagnosis and Management of Pancreatic Cysts 2012 ·Clinical Cancer Research ·Hanno Matthaei, Dennis Wylie, (unknown), Marco Dal Molin, Jon Kemppainen, Skye C. Mayo, Christopher L. Wolfgang, Richard D. Schulick, (unknown), Bernard F. Andruss, Alex Adai, Ralph H. Hruban, Anna E. Szafranska-Schwarzbach, Anirban Maitra	126
14	Perioperative management of patients undergoing pancreatic resection: Implementation of a care plan in a tertiary‐care center 2012 ·Journal of Surgical Oncology ·Roberto Salvia, Giuseppe Malleo, Giovanni Butturini, Marco Dal Molin, Alessandro Esposito, Giovanni Marchegiani, Salvatore Paiella, Anna Malpaga, Martina Fontana, (unknown), Claudio Bassi	17
15	Identification and Analysis of Precursors to Invasive Pancreatic Cancer 2012 ·Methods in molecular biology ·Hanno Matthaei, Marco Dal Molin, Anirban Maitra	21
16	GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct 2012 ·HPB ·Hanno Matthaei, Jian Wu, Marco Dal Molin, Marija Debeljak, Philipp Lingohr, Nora Katabi, David S. Klimstra, Volkan Adsay, James R. Eshleman, Richard D. Schulick, Kenneth W. Kinzler, Bert Vogelstein, Ralph H. Hruban, Anirban Maitra	39
17	Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development breakdown → 2011 ·Science Translational Medicine ·Jian Wu, Hanno Matthaei, Anirban Maitra, Marco Dal Molin, Laura D. Wood, James R. Eshleman, Michael Goggins, Marcia Irene Canto, Richard D. Schulick, Barish H. Edil, Christopher L. Wolfgang, Alison P. Klein, Luis A. Díaz, Peter J. Allen, C. Max Schmidt, Kenneth W. Kinzler, Nickolas Papadopoulos, Ralph H. Hruban, Bert Vogelstein	562
18	Presence of Pancreatic Intraepithelial Neoplasia in the Pancreatic Transection Margin does not Influence Outcome in Patients with R0 Resected Pancreatic Cancer 2011 ·Indian Journal of Surgical Oncology ·Hanno Matthaei, Seung‐Mo Hong, Skye C. Mayo, Marco Dal Molin, Kelly Olino, Raghunandan Venkat, Michael Goggins, Joseph M. Herman, Barish H. Edil, Christopher L. Wolfgang, John L. Cameron, Richard D. Schulick, Anirban Maitra, Ralph H. Hruban	2
19	Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas 2011 ·Human Pathology ·Marco Dal Molin, Seung‐Mo Hong, Sachidanand Hebbar, Rajni Sharma, Francesca Scrimieri, Roeland F. de Wilde, Skye C. Mayo, Michael Goggins, Christopher L. Wolfgang, Richard D. Schulick, Ming‐Tseh Lin, James R. Eshleman, Ralph H. Hruban, Anirban Maitra, Hanno Matthaei	49
20	Elevated microRNA miR-21 Levels in Pancreatic Cyst Fluid Are Predictive of Mucinous Precursor Lesions of Ductal Adenocarcinoma 2011 ·Pancreatology ·Ji Kon Ryu, Hanno Matthaei, Marco Dal Molin, Seung‐Mo Hong, Marcia Irene Canto, Richard D. Schulick, Christopher L. Wolfgang, Michael Goggins, Ralph H. Hruban, Leslie Cope, Anirban Maitra	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact